1255319
1226395
1226695
1226747
1226694
HIV-1 and TB co-infection skew the SARS-CoV-2 T cell response
SARS-CoV-2-specific CD4 T cell attributes, rather than magnitude, associate with disease severity, with severe disease being characterized by poor polyfunctional potential, reduced proliferation capacity and enhanced HLA-DR expression.
Image of scientist holding up a Petri dish
Supporting Excellence
The Wellcome Centre for Infectious Diseases Research in Africa fosters investigator-led approaches via the overarching scientific objective of combatting infection, especially HIV-1 and tuberculosis, through clinical and laboratory research.
Macrophages infected with M. tuberculosis; image by Dr Suraj Parihar
Basic Science
Our Basic Science Platform provides the laboratory infrastructure and technical support to ensure the safe handling of infectious material.
Subgraph of the ANIMA network for dataset HIVsetB
Biomedical Data Integration
We work with multidimensional clinical and scientific data at the molecular, cellular, clinical and population levels.
Image of a researcher and study participant reading an informed consent document
Clinical Research
CIDRI-Africa supports clinical studies in the community at our facility at Site B in Khayelitsha.

News

Friday, 24 September 2021
Investigating the dynamic inflammatory profile of tuberculosis patients with and without HIV-1 co-infection

Increased IL-17A network connectivity serves as an indicator of elevated systemic inflammation and immune activation induced by advanced HIV infection, and predicts mortality in patients with HIV-tuberculosis co-infection.

Publication Date:
Mon, 24 May 2021 - 08:30
Fire affecting the Rondebosch campus of the University of Cape Town (UCT)

No classes, tutorials, laboratory work or tests will take place on Monday, 19 April or Tuesday, 20 April. For safety reasons, campus will be locked down and no one, other than emergency services, will be allowed access.

Publication Date:
Mon, 19 Apr 2021 - 12:00
CIDRI-Africa enrolls first patient in the MESA-TB study

The phase 2 study will evaluate the safety and immunogenicity of the M72/AS01E TB vaccine in people living with HIV.

Publication Date:
Wed, 14 Apr 2021 - 11:45
A red alarm clock on grass
“The clock is ticking”: engaging youth on TB developments in the time of COVID-19

CIDRI-Africa in collaboration with City Health, WITS RHI, MSF, TB HIV Care, SWEAT and the Centre of Science and Technology hosted 130 school learners in Khayelitsha for World TB Day 2021.

Publication Date:
Fri, 26 Mar 2021 - 09:30

Pages

TOP